Our Experience Pharmacomechanic Thrombectomy Case In Deep Vein Thrombosis.

Ocak 22, 2025 - 19:35
0 33

Pharmacomechanical Thrombectomy is a current treatment approach in acute iliofemoroal DVT. However, it is important that the cases are acute. The devices used in cases exceeding 15 days can remain in the vein by holding on to the fibrin ligaments. Pharmacomechanical devices, especially used over the guide wire, provide us with easy use in practice. The passage of devices can be difficult. From time to time, cava filters may need to be inserted in addition to pharmacomechanical treatment, especially in cases with pulmonary embolism risk. Pharmacomechanical DVT treatment (Peripheral vascular Longıtudınal Pharmacomechanic Thrombolysis/Thrombectomy Catheter Mavera) was applied to 25 DVT cases in our clinic, and all of the cases were acute DVT. In only 2 cases, a temporary filter was inserted into the inferior venous cava (Effacer Perıpehral Vascular Thrombolysıs Catheter with Filter, Mavera). The venous flow of the patients was fully opened. The procedure times were approximately 45 minutes from the time they were brought to the table. The Caval temporary filter was 1 day after the procedure. withdrew. Pharmacomechanical DVT treatment has satisfactory results in acute DVT. It is an important method in the treatment of iliofemoral DVT. It reduces the risk of postphlebitic syndrome and pulmonary embolism.